Search Results

0 results for 'Janssen Biotech, Inc.'

You can use to get even better search results
March 04, 2019 | The Recorder

Latham Breaks Records Again as Revenue Soars, Profit Jumps

Latham pulled in nearly $3.4 billion in its 10th straight year of revenue growth, as the firm's leadership says clients are seeking out its lawyers in more places than ever.
5 minute read
March 01, 2019 | The American Lawyer

Latham Breaks Records Again as Revenue Soars, Profit Jumps

Latham pulled in nearly $3.4 billion in its 10th straight year of revenue growth, as the firm's leadership says clients are seeking out its lawyers in more places than ever.
5 minute read
March 01, 2019 | New York Law Journal

Latham Breaks Records Again as Revenue Soars, Profit Jumps

The firm in January hired David Beller, a private equity and M&A lawyer, from Paul Weiss Rifkind Wharton & Garrison in New York. Latham also lured Alexander Johnson, former head of the M&A practice in the Manhattan offices of Hogan Lovells.
5 minute read
February 08, 2019 | Litigation Daily

Litigators of the Week: Latham's Lethal IP Litigators Kill Patent Challenge to $2B-a-Year Drug

Latham & Watkins global IP co-chair Michael Morin and partner David Frazier delivered a save worth billions to clients Janssen Biotech Inc. and Genmab A/S.
10 minute read
February 01, 2019 | Law.com

Skilled in the Art: Judge Busts Novel FRAND Theory | Unified Weighs In on Video Codec Royalties | Still No Gusher From Oil States

Judge Cathy Ann Bencivengo wasted little time in ruling against u-blox's bid to enjoin InterDigital Inc. from contacting its customers while the court determines a fair, reasonable and nondiscriminatory rate.
9 minute read
January 30, 2019 | Litigation Daily

Daily Dicta: Gwyneth Paltrow Slammed with $3M Suit for Utah Ski Collision

'Gwyneth Paltrow knew it was wrong to slam into Dr. Sanderson's back, knocking him down, landing on top of him, knocking him out and then leave the scene of the ski crash she caused,' states the complaint filed in Utah state court.
5 minute read
January 28, 2019 | National Law Journal

Latham Blocks Patent Attack on $2 Billion-a-Year Blood Cancer Drug

MorphoSys and Kirkland & Ellis had accused a Janssen Pharmaceuticals biologic of infringing, but Judge Leonard Stark ruled MorphoSys' patents invalid for lack of enablement.
3 minute read
January 28, 2019 | Litigation Daily

Latham Defeats Patent Attack on $2 Billion-a-Year Blood Cancer Drug

MorphoSys and Kirkland & Ellis had accused a Janssen Pharmaceuticals biologic of infringing, but Judge Leonard Stark ruled MorphoSys' patents invalid for lack of enablement.
3 minute read
In re: Remicade Antitrust Litig.
Publication Date: 2018-02-13
Practice Area: Antitrust | Class Actions
Industry: Biotechnology | Legal Services
Court: U.S. District Court for Pennsylvania - Eastern
Judge: District Judge Joyner
Attorneys:
For plaintiff:
For defendant:
Case number: 18-0143

Court appointed single-firm structure for interim class counsel where risks of increased costs and difficulty in managing multi-firm structure outweighed any benefits multi-firm structure had in effectively serving prospective class. Plaintiffs application to appoint interim class counsel granted.

MorphoSys AG v. Janssen Biotech, Inc.
Publication Date: 2017-11-08
Practice Area: Intellectual Property | Patent Litigation
Industry: Biotechnology
Court: U.S. District Court of Delaware
Judge: District Judge Stark
Attorneys:
For plaintiff: Kelly E. Farnan, Christine D. Haynes, James F. Hurst, Patricia A. Carson, Christopher T. Jagoe and Aa-ron D. Resetarits for plaintiff
For defendant: Jack B. Blumenfeld, Brian P. Egan, Michael A. Morin, David P. Frazier, Emily K. Sauter, Roger J. Chin and Michael R. Seringhaus for defendants.
Case number: D67932

The court construed disputed terms in this patent infringement matter involving pharmaceuticals.

TRENDING STORIES

    Resources

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now